CONSORT-PRECIS 扩展方案:基于 PRECIS 工具设计务实与解释性试验的报告规范
本方案拟更新 2008 年发布的 CONSORT 务实试验扩展版,采用范围综述、国际专家组德尔菲共识、指南定稿、报告工具开发与试点测试五步流程。更新后的 CONSORT-PRECIS 将覆盖使用 PRECIS 工具设计、明确声明务实或解释意图的随机对照试验,强调清晰报告试验意图、设计选择、场所、干预实施、结局与分析,以提升结果透明度及对临床决策的适用性。
要点
- 更新 2008 年 CONSORT 务实试验扩展,覆盖务实与解释两类试验意图。
- 采用范围综述与德尔菲共识等五步流程制定报告规范。
- 强调报告试验意图、设计选择、场所、干预实施、结局与分析。
核心结论
- 更新后的 CONSORT-PRECIS 扩展旨在提升务实与解释性试验报告的透明度和完整性。
- 该规范期望支持知情医疗决策、增进对试验结果的信任并推进科学知识。
研究设计与样本
- 本方案为研究方案,拟更新 2008 年发表的 CONSORT 务实试验扩展版。
- 制定流程包括五步:范围综述、国际专家组德尔菲共识、指南定稿、报告工具开发与试点测试。
- 德尔菲专家组涵盖试验研究者、方法学家、临床医生、政策决策者、生物统计学家、监管代表、研究资助者、期刊编辑与患者伙伴。
临床怎么用
- 使用 PRECIS 工具设计并声明务实或解释意图的随机对照试验,应按更新后的 CONSORT-PRECIS 报告试验意图、设计选择、场所、干预实施、结局与分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: This research protocol outlines a systematic approach to updating the Consolidated Standards of Reporting Trials (CONSORT) extension for pragmatic trials, originally published in 2008. Pragmatic trials, whose intention is to provide evidence for real-world decision-makers choosing between alternative interventions, differ in design from explanatory trials, whose intention is to test hypotheses about mechanisms of action, often under tightly controlled conditions that may be contrived compared with usual care. As the understanding of trials with explanatory and pragmatic intentions has evolved, there is a need to revise the reporting guidelines to better align with current best practices and emerging challenges. METHODS: This protocol updates the previous CONSORT extension for pragmatic trials and involves five key steps: conducting a scoping review to identify relevant literature; engaging an international panel of trialists, trial methodologists, clinicians, policy decision-makers, biostatisticians, regulatory representatives, research funders, journal editors, and patient partners in a Delphi process to achieve consensus on necessary updates; finalizing the revised guidelines; developing the reporting guidance product; and pilot testing the product. RESULTS: The updated CONSORT extension for randomized controlled trials with declared pragmatic or explanatory intentions designed using the PRECIS tool (CONSORT-PRECIS) will emphasize clear reporting of trial intention, design choices, settings, intervention delivery, outcomes, and analyses to enhance understanding of trial findings and their applicability to clinical practice and decision-making or, alternatively, the testing of mechanistic hypotheses. CONCLUSION: By improving the transparency and completeness of reporting for both pragmatic and explanatory trials, the updated CONSORT-PRECIS extension aims to support informed healthcare decisions, promote trust in trial results, and advance scientific knowledge.
引用
- Ng JY, Zwarenstein M, Barzideh A, et al. Protocol for a CONSORT extension for reporting pragmatic and explanatory trials designed using the PRECIS tool (CONSORT-PRECIS). J Clin Epidemiol. 2026. PMID: 42297053. doi:10.1016/j.jclinepi.2026.112379
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。